Dear Ms. Bear: As you are now fully aware, a number of HDC

New Post Public Reply Private Reply Replies (0) Message Board
MBMoney
283
Dear Ms. Bear:
As you are now fully aware, a number of HDC shareholders have very serious concerns relative to the actions of you, Mr. Quirk, and likely others (who may be helping to fund your cause and who have not been appropriately disclosed), in filing a complaint against the current HDC board. For that matter, it is clear to me that you are under-estimating just how serious this entire scenario is, particularly since you can’t deny that it has been well-orchestrated, and you and Mr. Quirk deliberately presented this information to HDC shareholders via message boards in a deceptive manner.
Further, as you know, there are a number of issues in your letter that enabled me to quickly realize that you were being less-than honest. One of these issues, which is literally laughable, relates to the following statement in your letter: “The decisions of HDC’s management and directors over the past few years, combined with recent external developments, have now led me to conclude that a Special Meeting of Shareholders is essential, and soon.” Which decisions would those be? Would they include the decision to vigorously pursue an arbitration proceeding with Neogenomics, and prevail? As I understand it, that decision was against the approach desired by Mr. Kowbel and Mr. Quirk, wasn’t it? Or, would they include the decision to seek a 5-year patent term extension for the SVM-RFE technology, and prevail? Perhaps you get the point.
Therefore, since you have portrayed to HDC shareholders that you are sincere in your efforts, you should have absolutely no problem answering the following questions and posting your answers for shareholders. It doesn’t matter whether shareholders support you and Mr. Quirk, whether they support the current team, or whether they just don’t care. What is important is that you now have an obligation to provide all of us with honest answers, since we all have a legitimate right to be appropriately informed.
1. Did you write your own letter, or did you have the assistance or guidance of Mr. Quirk and/or others? For that matter, why did Mr. Quirk not sign the letter?
2. It is not plausible that you and Mr. Quirk are funding this complaint process out of your own pockets. Your entire approach serves to reveal that you are not the type of person who would finance this entire process out of the ‘kindness of your own heart.’ Thus, HDC shareholders have a right to know the following: Who are the individuals who are helping to fund it, and why haven’t they been appropriately disclosed to shareholders?
3. Who are the individuals on your proposed slate of candidates for a new board?
4. Why did you and Mr. Quirk include in your complaint that you desire access to past and present shareholders? Do you believe that, as a shareholder (no different than the rest of us), you have a right to this information, yet I don’t?
5. Who has helped orchestrate the process of posting continually negative messages on the message boards, while going so far as to change aliases? This obviously didn’t occur by accident, and the presence of these individuals coincides with your efforts. Accordingly, don’t you believe that you have an obligation to divulge the truth? Who are these individuals, and who is “James”?
6. You referenced in your shareholder letter the following: “Georgia law allows shareholders owning 25% of the outstanding shares to call a Special Meeting. To that end over 80 stockholders owning more than 75 million shares, or 25% of all outstanding shares (based on information publicly disclosed to the shareholders) sent a letter to the Company demanding a Special Meeting.” Ms. Bear, I have numerous emails that came directly from Mr. Quirk over the years, and I know first-hand that he has been, for quite a period of time, asking for shareholders to provide him with the number of shares they own. Don’t you find it odd, then, that his requests date back to the period PRIOR to HDC’s successes with Intel and Neogenomics? Further, are you aware, Ms. Bear, that Mr. Quirk was signifying that HDC needed new leadership, PRIOR to these successes?
Ms. Bear, I have nothing to hide. I’m a shareholder who holds more shares than you, has invested longer than you, and who has obviously supported the COMPANY well beyond any efforts you have put forth. You obviously think you can prey on those shareholders whom you believe won’t take the time to review the information thoroughly. Yet, as you can tell, I do my homework.
Answer the questions, Ms. Bear.

Health Discovery Cp (HDVY) Stock Research Links

HDVY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 608

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 360

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 23

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 149

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 124

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 38

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 467

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 187

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 101

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 481

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Homebuyers Benefit as Mortgage Rates Hit New Lows

Updated Category News Views 110

Mortgage Rates See a Significant Drop Recent data shows that mortgage rates have fallen to their lowest point in more than 18 months. This presents a prime opportunity for homebuyers who might be thinking about refinancing their current loans. The drop in rates can be linked to various market dynamics, which has led to a noticeable spike in refinancing activity. Current...

Continue Reading
Cross River Bank Launches Innovative FDIC Sweep Service

Updated Category News Views 195

Introducing Cross River's Automated Sweep Feature Cross River Bank, a pioneering technology infrastructure provider known for its innovative embedded financial solutions, has recently unveiled its automated sweep feature leveraging the IntraFi Cash Service. This groundbreaking service allows Cross River's Banking-as-a-Service (BaaS) clients to access enhanced FDIC...

Continue Reading
Understanding P/E Ratio and Its Importance for PNC Investors

Updated Category News Views 198

Understanding the P/E Ratio for PNC Financial Services Group In today’s trading session, PNC Financial Services Group’s stock is valued at $187.43, reflecting a slight increase of 0.87%. Looking at the broader picture, the stock of PNC Financial Services Group Inc. has risen by an impressive 4.19% over the past month and a remarkable 63.74% in the past year. These...

Continue Reading
Grace Therapeutics Sees Positive Outcomes and Business Growth

Updated Category News Views 224

Grace Therapeutics Reports Promising Progress and Financial Update Grace Therapeutics, Inc. (NASDAQ: GRCE), a biopharmaceutical company dedicated to advancing treatment solutions, has just shared significant news regarding its fiscal operations and pivotal clinical advancements. The company focuses on developing GTx-104, a promising injectable formulation of nimodipine...

Continue Reading
Jordan G. Welch's Worship Culture Tour: A Transformative Experience

Updated Category News Views 643

Jordan G. Welch's Worship Culture Tour Unleashes New Dimensions in Worship The Worship Culture Tour is set to launch with a vibrant focus on creating an immersive worship experience that extends beyond traditional confines. This exciting two-day event will guide participants through a journey of spiritual growth across multiple cities, inviting people from all walks of...

Continue Reading